نتائج البحث - "Immunotherapy, Adoptive/adverse effects"

1

دورية أكاديمية

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network.

المصدر: The Lancet Oncology, 24 (6), e255 - e269 (2023-06)

العلاقة: https://api.elsevier.com/content/article/PII:S1470204523001596?httpAccept=text/xmlTest; urn:issn:1470-2045; urn:issn:1474-5488

الوصول الحر: https://orbi.uliege.be/handle/2268/310482Test

View record in ORBi

2

Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)

المؤلفون: Olaf Penack, Zinaida Peric, Muhammad Saif, Montserrat Rovira, Rachel Tattersall, Manuela Badoglio, Robert David Sandler, Tobias Alexander, Christian Koenecke, Kirill Kirgizov, Julio Delgado, Hélène Schoemans, John A. Snowden, Myriam Labopin, Raffaella Greco, Grzegorz W. Basak, Riccardo Saccardi

المساهمون: University Hospitals Leuven [Leuven], Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale San Raffaele, Laboratoire d'Hématologie et d'Immunologie [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Centre International des greffes [CHU Saint-Antoine] (EBMT), Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], N.N. Blokhin Russian Cancer Research Center, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Manchester Royal Infirmary, University of Manchester [Manchester], University of Zagreb, Hannover Medical School [Hannover] (MHH), Medical University of Warsaw - Poland

المصدر: Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2020, 11, ⟨10.3389/fimmu.2020.00524⟩

مصطلحات موضوعية: 0301 basic medicine, Male, CYCLOSPORINE-A, [SDV]Life Sciences [q-bio], CAR-T cell, GVHD, Immunotherapy, Adoptive / adverse effects, CHILDREN, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, Immunotherapy, Adoptive, RECOMMENDATIONS, Cell therapy, 0302 clinical medicine, Lymphohistiocytosis, Hemophagocytic / therapy, Surveys and Questionnaires, Immunology and Allergy, SERUM FERRITIN, JUVENILE IDIOPATHIC ARTHRITIS, Original Research, Receptors, Chimeric Antigen, Macrophage Activation Syndrome, Hematopoietic Stem Cell Transplantation, Middle Aged, 3. Good health, Cytokine release syndrome, Macrophage Activation Syndrome / etiology, HSCT, Female, HLH hemophagocytic lymphohistiocytosis, Life Sciences & Biomedicine, Adult, lcsh:Immunologic diseases. Allergy, medicine.medical_specialty, Immunology, macrophage activation syndrome (MAS), Malignancy, Lymphohistiocytosis, Hemophagocytic, 03 medical and health sciences, Internal medicine, Transplant complications, HYPERFERRITINEMIA, medicine, Humans, Lymphohistiocytosis, Hemophagocytic / diagnosis, Lymphohistiocytosis, Hemophagocytic / etiology, MACROPHAGE ACTIVATION SYNDROME, Science & Technology, Macrophage Activation Syndrome / therapy, business.industry, CLINICAL-FEATURES, ferritin, Hematopoietic Stem Cell Transplantation / adverse effects, biomarkers, medicine.disease, EFFICACY, Transplantation, 030104 developmental biology, Macrophage Activation Syndrome / diagnosis, Macrophage activation syndrome, CAR T-cell therapy, business, Complication, lcsh:RC581-607, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, 030215 immunology

وصف الملف: application/pdf; Electronic-eCollection

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d4f7afb2b6a7e74bf517d9fae4c4c2dTest
https://www.frontiersin.org/article/10.3389/fimmu.2020.00524/fullTest

3

Safety and Tolerability of Adoptive Cell Therapy in Cancer

المؤلفون: Wolf, B., Zimmermann, S., Arber, C., Irving, M., Trueb, L., Coukos, G.

المصدر: Drug safety, vol. 42, no. 2, pp. 315-334

مصطلحات موضوعية: Animals, Antineoplastic Agents/adverse effects, Antineoplastic Agents/pharmacology, Antineoplastic Agents/therapeutic use, Clinical Trials as Topic/methods, Humans, Immunotherapy, Adoptive/adverse effects, Immunotherapy, Adoptive/methods, Neoplasms/drug therapy, Neoplasms/immunology, Neoplasms/metabolism, Nervous System Diseases/chemically induced, Nervous System Diseases/metabolism, T-Lymphocytes/drug effects, T-Lymphocytes/immunology, T-Lymphocytes/metabolism

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1900::4ca7bfc02d71c7b659ca65ef5c64c9a2Test
https://serval.unil.ch/notice/serval:BIB_944ED4AF4291Test

4

CARs in the Lead Against Multiple Myeloma

المؤلفون: Matthew J. Frigault, Maria Ormhøj, Marcela V. Maus, Felipe Bedoya

المصدر: Ormhøj, M, Bedoya, F, Frigault, M J & Maus, M V 2017, ' CARs in the Lead Against Multiple Myeloma ', Current Hematologic Malignancy Reports, vol. 12, no. 2, pp. 119–125 . https://doi.org/10.1007/s11899-017-0373-2Test

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, T-Lymphocytes, T-Cell Antigen Receptor Specificity, Immunotherapy, Adoptive, Clinical trials, Multiple Myeloma/immunology, 0302 clinical medicine, Multiple myeloma, immune system diseases, hemic and lymphatic diseases, Chimeric antigen receptor, Immunotherapy, Adoptive/adverse effects, Antigens, Neoplasm/immunology, Clinical Trials as Topic, Hematology, biology, Adoptive T cell therapy, medicine.anatomical_structure, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Stem cell, Multiple Myeloma, medicine.medical_specialty, Receptors, Antigen, T-Cell/genetics, Myeloma protein, T cell, Recombinant Fusion Proteins, Receptors, Antigen, T-Cell, CD19, Article, 03 medical and health sciences, Antigen, Antigens, Neoplasm, Internal medicine, medicine, Humans, Recombinant Fusion Proteins/genetics, business.industry, T-Cell Antigen Receptor Specificity/immunology, T-Lymphocytes/immunology, medicine.disease, B cell maturation antigen, 030104 developmental biology, Immunology, Cancer research, biology.protein, business